UY32052A - 5-aminopirazoles sustituidos y uso de los mismos - Google Patents
5-aminopirazoles sustituidos y uso de los mismosInfo
- Publication number
- UY32052A UY32052A UY0001032052A UY32052A UY32052A UY 32052 A UY32052 A UY 32052A UY 0001032052 A UY0001032052 A UY 0001032052A UY 32052 A UY32052 A UY 32052A UY 32052 A UY32052 A UY 32052A
- Authority
- UY
- Uruguay
- Prior art keywords
- aminopirazols
- replaced
- same
- prophylaxis
- diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La presente solicitud se refiere a 5-aminopirazoles sustituidos novedosos, a los procedimientos de producción de los mismos, al uso de los mismos, al uso de los mismos solos o en combinaciones para el tratamiento y/o profilaxis de enfermedades y uso de los mismos para la producción de productos medicinales para el tratamiento y/o profilaxis de enfermedades.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102008039083A DE102008039083A1 (de) | 2008-08-21 | 2008-08-21 | Substituierte 5-Aminopyrazole und ihre Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
UY32052A true UY32052A (es) | 2010-03-26 |
Family
ID=41100577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001032052A UY32052A (es) | 2008-08-21 | 2009-08-14 | 5-aminopirazoles sustituidos y uso de los mismos |
Country Status (11)
Country | Link |
---|---|
US (1) | US20100099681A1 (es) |
EP (1) | EP2321296A1 (es) |
JP (1) | JP2012500236A (es) |
KR (1) | KR20110042082A (es) |
CN (1) | CN102197031A (es) |
AR (1) | AR073064A1 (es) |
CA (1) | CA2734787A1 (es) |
DE (1) | DE102008039083A1 (es) |
TW (1) | TW201022225A (es) |
UY (1) | UY32052A (es) |
WO (1) | WO2010020363A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2871179A4 (en) | 2012-07-03 | 2016-03-16 | Ono Pharmaceutical Co | CONNECTION WITH AGONISTIC EFFECT ON THE SOMATOSTATIN RECEPTOR AND ITS USE FOR MEDICAL PURPOSES |
EP3010908A1 (en) | 2013-02-20 | 2016-04-27 | E. I. du Pont de Nemours and Company | Fungicidal pyrazoles |
WO2016092559A1 (en) * | 2014-12-12 | 2016-06-16 | Oat & Iil India Laboratories Private Limited | Substituted pyrazole derivatives having activity as fungicides |
WO2018052838A1 (en) | 2016-09-16 | 2018-03-22 | E. I. Du Pont De Nemours And Company | Fungicidal pyrazoles |
AU2017357488A1 (en) | 2016-11-08 | 2019-06-20 | Merck Patent Gmbh | Substituted quinoxaline derivatives as inhibitors of PFKFB |
EP3354645A1 (en) * | 2017-01-26 | 2018-08-01 | Patheon Austria GmbH & Co KG | Process for preparing urolithins |
EP3759087A1 (en) | 2018-02-27 | 2021-01-06 | Amazentis SA | Process-scale synthesis of urolithin a |
TWI819078B (zh) | 2018-09-06 | 2023-10-21 | 美商富曼西公司 | 殺真菌之經硝苯胺基取代之吡唑 |
AU2020257301A1 (en) | 2019-04-18 | 2021-11-11 | The Johns Hopkins University | Substituted 2-amino-pyrazolyl-(1,2,4)triazolo(1,5a) pyridine derivatives and use thereof |
TW202200012A (zh) | 2020-03-11 | 2022-01-01 | 美商富曼西公司 | 殺真菌劑混合物 |
CN113372200B (zh) * | 2021-07-12 | 2022-04-19 | 无锡双启科技有限公司 | 一种2-溴-6-氟苯甲醚的制备方法 |
CN114773333A (zh) * | 2021-12-25 | 2022-07-22 | 上海泰坦科技股份有限公司 | 一种卤代三唑并吡啶的合成方法 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5201938A (en) | 1991-07-19 | 1993-04-13 | Dowelanco | N-pyrazolyl-1,2,4-triazolo[1,5-c]pyrimidine-2-sulfonamide herbicides |
BR9305466A (pt) | 1992-03-26 | 1994-12-20 | Dowelanco | Nitroanilinas n-heterocíclicas usadas como fungicidas |
US5541213A (en) * | 1993-06-24 | 1996-07-30 | Eisai Co., Ltd. | Propenoic acid derivatives diazole propenoic acid compounds which have useful pharmaceutical utility |
JPH07285962A (ja) | 1994-04-20 | 1995-10-31 | Nissan Chem Ind Ltd | ピリジンカルボン酸アミド誘導体 |
DE19834044A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
DE19834047A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Substituierte Pyrazolderivate |
DE19943635A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19943639A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften |
DE19943634A1 (de) | 1999-09-13 | 2001-04-12 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19943636A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
AR031176A1 (es) | 2000-11-22 | 2003-09-10 | Bayer Ag | Nuevos derivados de pirazolpiridina sustituidos con piridina |
DE10110750A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE10110749A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Substituierte Aminodicarbonsäurederivate |
DE10220570A1 (de) | 2002-05-08 | 2003-11-20 | Bayer Ag | Carbamat-substituierte Pyrazolopyridine |
UY27967A1 (es) | 2002-09-10 | 2004-05-31 | Pfizer | Acetil 2-hindroxi-1,3-diaminoalcanos |
AR042067A1 (es) | 2002-11-27 | 2005-06-08 | Bayer Pharmaceuticals Corp | Derivados de anilinopirazol utiles en el tratamiento de la diabetes |
WO2005009445A1 (en) * | 2003-07-22 | 2005-02-03 | Cv Therapeutics, Inc. | A1 adenosine receptor antagonists |
AR049418A1 (es) | 2004-02-27 | 2006-08-02 | Bayer Pharmaceuticals Corp | Derivados de heteroarilaminopirazol y composiciones farmaceuticas para el tratamiento de la diabetes. |
JP2007538102A (ja) | 2004-05-20 | 2007-12-27 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | 糖尿病の処置に有用な5−アニリノ−4−ヘテロアリールピラゾール誘導体 |
MXPA06014798A (es) | 2004-06-17 | 2007-06-22 | Wyeth Corp | Antagonistas del receptor de hormona para liberar gonadotropina. |
JP2009506127A (ja) | 2005-08-31 | 2009-02-12 | バイエル・ヘルスケア・エルエルシー | 糖尿病の処置に有用なアニリノピラゾール誘導体 |
JP2009542809A (ja) | 2006-07-12 | 2009-12-03 | メルク エンド カムパニー インコーポレーテッド | グレリン受容体アンタゴニストとしての置換ピラゾール |
US20100222345A1 (en) | 2006-08-09 | 2010-09-02 | Caroline Jean Diaz | Novel compounds as antagonists or inverse agonists for opioid receptors |
-
2008
- 2008-08-21 DE DE102008039083A patent/DE102008039083A1/de not_active Withdrawn
-
2009
- 2009-08-11 CN CN2009801418695A patent/CN102197031A/zh active Pending
- 2009-08-11 KR KR1020117003762A patent/KR20110042082A/ko not_active Application Discontinuation
- 2009-08-11 CA CA2734787A patent/CA2734787A1/en not_active Abandoned
- 2009-08-11 JP JP2011523333A patent/JP2012500236A/ja active Pending
- 2009-08-11 EP EP09777798A patent/EP2321296A1/en not_active Withdrawn
- 2009-08-11 WO PCT/EP2009/005810 patent/WO2010020363A1/en active Application Filing
- 2009-08-13 US US12/540,657 patent/US20100099681A1/en not_active Abandoned
- 2009-08-14 AR ARP090103152A patent/AR073064A1/es unknown
- 2009-08-14 UY UY0001032052A patent/UY32052A/es not_active Application Discontinuation
- 2009-08-20 TW TW098127965A patent/TW201022225A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
JP2012500236A (ja) | 2012-01-05 |
EP2321296A1 (en) | 2011-05-18 |
US20100099681A1 (en) | 2010-04-22 |
DE102008039083A1 (de) | 2010-02-25 |
KR20110042082A (ko) | 2011-04-22 |
AR073064A1 (es) | 2010-10-13 |
CA2734787A1 (en) | 2010-02-25 |
WO2010020363A1 (en) | 2010-02-25 |
TW201022225A (en) | 2010-06-16 |
CN102197031A (zh) | 2011-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY32052A (es) | 5-aminopirazoles sustituidos y uso de los mismos | |
DOP2014000255A (es) | Uracilos sustituidos bicíclicamente y uso de los mismos | |
HN2011002406A (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso | |
GT201200250A (es) | Ariltriazolonas ligadas a bisarilo y su uso | |
GT201400033A (es) | Pirimidinas anilladas sustituidas y uso de las mismas | |
GT200900230A (es) | 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso | |
UY31228A1 (es) | Ariloxazoles sustituidos y su uso | |
PA8772101A1 (es) | Imidazol-triazolopirimidinas sustituidas | |
CR20110407A (es) | Dicianopiridinas alquilamino-sustituidas y sus profármacos de éster de aminoácido | |
CR11684A (es) | Dihidropirazolonas sustituidas de hif-propil-4- como inhibidores hidroxilasa | |
UY35693A (es) | Pirazolo[1,5-a]piridin-3-carboxamidas sustituidas y su uso | |
DOP2007000043A (es) | Derivados de cromanol sustituidos y su uso | |
CR20110318A (es) | Compuestos, composición farmacéutica y métodos para utilizarse en el tratamiento de trastornos metabólicos | |
CR20110210A (es) | Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales | |
DOP2009000285A (es) | (oxazolidinon-5-il-metil)-2-tiofen-carboxamidas sustituidas y su uso en el campo de la coagulacion sanguinea. | |
SV2009002953A (es) | Nuevos derivados de furopirimidina aciclicos sustituidos y su uso | |
SV2010003773A (es) | 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos | |
BR112013020359B8 (pt) | Colágeno gelificável e meios para a sua provisão | |
CU20080122A7 (es) | Nuevos derivados de furopirimidina acíclicos sustituidos y su uso | |
CU20100260A7 (es) | 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos | |
HN2008000946A (es) | Nuevos derivados de furopirimidina aciclicos sustituidos | |
NI201200162A (es) | Inhibidores de pirazolil quinoxalina cinasa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20181112 |